Literature DB >> 20926130

The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

Torjus Skajaa1, David P Cormode, Peter A Jarzyna, Amanda Delshad, Courtney Blachford, Alessandra Barazza, Edward A Fisher, Ronald E Gordon, Zahi A Fayad, Willem J M Mulder.   

Abstract

Lipoproteins are a family of plasma nanoparticles responsible for the transportation of lipids throughout the body. High-density lipoprotein (HDL), the smallest of the lipoprotein family, measures 7-13 nm in diameter and consists of a cholesteryl ester and triglyceride core that is covered with a monolayer of phospholipids and apolipoproteins. We have developed an iron oxide core HDL nanoparticle (FeO-HDL), which has a lipid based fluorophore incorporated in the phospholipid layer. This nanoparticle provides contrast for optical imaging, magnetic resonance imaging (MRI) and transmission electron microscopy (TEM). Consequently, FeO-HDL can be visualized on the anatomical, cellular and sub-cellular level. In the current study we show that the biophysical features of FeO-HDL closely resemble those of native HDL and that FeO-HDL possess the ability to mimic HDL characteristics both in vitro as well as in vivo. We demonstrate that FeO-HDL can be applied to image HDL interactions and to investigate disease settings where HDL plays a key function. More generally, we have demonstrated a multimodal approach to study the behavior of biomaterials in vitro as well as in vivo. The approach allowed us to study nanoparticle dynamics in circulation, as well as nanoparticle targeting and uptake by tissues and cells of interest. Moreover, we were able to qualitatively assess nanoparticle excretion, critical for translating nanotechnologies to the clinic.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20926130      PMCID: PMC3576133          DOI: 10.1016/j.biomaterials.2010.08.078

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  30 in total

1.  Electron microscopy of negatively stained lipoproteins.

Authors:  T M Forte; R W Nordhausen
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein.

Authors:  J P Segrest; M K Jones; A E Klon; C J Sheldahl; M Hellinger; H De Loof; S C Harvey
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.

Authors:  S Acton; A Rigotti; K T Landschulz; S Xu; H H Hobbs; M Krieger
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

Review 4.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Interaction of bovine serum high density lipoprotein with mixed vesicles of phosphatidylcholine and cholesterol.

Authors:  A Jonas
Journal:  J Lipid Res       Date:  1979-09       Impact factor: 5.922

Review 6.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-14       Impact factor: 29.690

Review 7.  Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes.

Authors:  Juan F Viles-Gonzalez; Valentin Fuster; Roberto Corti; Juan J Badimon
Journal:  Curr Opin Cardiol       Date:  2003-07       Impact factor: 2.161

8.  The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.

Authors:  W S Davidson; S Lund-Katz; W J Johnson; G M Anantharamaiah; M N Palgunachari; J P Segrest; G H Rothblat; M C Phillips
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

Review 9.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

10.  Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.

Authors:  Alan T Remaley; Fairwell Thomas; John A Stonik; Steve J Demosky; Samantha E Bark; Edward B Neufeld; Alexander V Bocharov; Tatyana G Vishnyakova; Amy P Patterson; Thomas L Eggerman; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

View more
  29 in total

Review 1.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

2.  High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein.

Authors:  David P Cormode; Edward A Fisher; Erik S G Stroes; Willem J M Mulder; Zahi A Fayad
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

Review 3.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

Authors:  Mark E Lobatto; Valentin Fuster; Zahi A Fayad; Willem J M Mulder
Journal:  Nat Rev Drug Discov       Date:  2011-10-21       Impact factor: 84.694

Review 4.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

5.  Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.

Authors:  Pratap C Naha; Kristen C Lau; Jessica C Hsu; Maryam Hajfathalian; Shaameen Mian; Peter Chhour; Lahari Uppuluri; Elizabeth S McDonald; Andrew D A Maidment; David P Cormode
Journal:  Nanoscale       Date:  2016-07-14       Impact factor: 7.790

6.  Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.

Authors:  Bhabatosh Banik; Ru Wen; Sean Marrache; Anil Kumar; Nagesh Kolishetti; Elizabeth W Howerth; Shanta Dhar
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

7.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

8.  Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

Authors:  Ian R Corbin; Kenneth K Ng; Lili Ding; Andrea Jurisicova; Gang Zheng
Journal:  Nanomedicine (Lond)       Date:  2012-10-15       Impact factor: 5.307

Review 9.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

10.  Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.

Authors:  Francois Fay; Brenda L Sanchez-Gaytan; David P Cormode; Torjus Skajaa; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Curr Cardiovasc Imaging Rep       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.